Literature DB >> 25277962

Aquaporin-1 antibody in neuromyelitis optical patients.

Erdem Tüzün1, John Tzartos, Esme Ekizoğlu, Christos Stergiou, Paraskevi Zisimopoulou, Arzu Coban, Erkingül Shugaiv, Recai Türkoğlu, Murat Kürtüncü, Betül Baykan, Socrates Tzartos.   

Abstract

BACKGROUND/
METHODS: To find out the prevalence of aquaporin-antibody (Aqp-Ab) and characterize Aqp-Ab associated clinical features in NMO, Aqp-1 and Aqp-4-Abs were examined using radioimmunoprecipitation and cell-based assays, respectively.
RESULTS: Aqp-4 and Aqp-1-Abs were detected in 20/30 and 8/30 NMO patients, respectively. One patient was Aqp-1-Ab single-positive, 13 patients were Aqp-4-Ab single-positive, 7 patients were Aqp-4/Aqp-1-Ab double-positive and 9 patients were seronegative. All double-positive patients had optic neuritis during the first attack. Only 2/29 MS patients and none of the control idiopathic intracranial hypertension patients were Aqp-1-Ab positive.
CONCLUSION: Aqp-1-Ab is usually detected in Aqp-4-Ab positive NMO patients and might be involved in optic neuritis pathogenesis.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25277962     DOI: 10.1159/000364904

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  9 in total

Review 1.  Experimental models of neuromyelitis optica: current status, challenges and future directions.

Authors:  Minshu Li; Yaping Yan
Journal:  Neurosci Bull       Date:  2015-06-24       Impact factor: 5.203

2.  Antibodies to aquaporin-1 are not present in neuromyelitis optica.

Authors:  Kathrin Schanda; Patrick Waters; Hannah Holzer; Fahmy Aboulenein-Djamshidian; M Isabel Leite; Jacqueline Palace; Sandra Vukusic; Romain Marignier; Thomas Berger; Markus Reindl
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-10-01

3.  A Rare Presentation of Neuromyelitis Optica Spectrum Disorders.

Authors:  Navneet K Singh; Alexander J Sweidan; Sarah Strube; Ignacio Carrillo-Nunez
Journal:  Clin Med Insights Case Rep       Date:  2018-02-05

Review 4.  The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.

Authors:  Michalina Jasiak-Zatonska; Alicja Kalinowska-Lyszczarz; Slawomir Michalak; Wojciech Kozubski
Journal:  Int J Mol Sci       Date:  2016-03-02       Impact factor: 5.923

5.  Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders.

Authors:  Ismael Sánchez Gomar; María Díaz Sánchez; Antonio José Uclés Sánchez; José Luis Casado Chocán; Nela Suárez-Luna; Reposo Ramírez-Lorca; Javier Villadiego; Juan José Toledo-Aral; Miriam Echevarría
Journal:  Int J Mol Sci       Date:  2016-07-23       Impact factor: 5.923

Review 6.  Aquaporins in the Spinal Cord.

Authors:  Michal K Oklinski; Mariusz T Skowronski; Agnieszka Skowronska; Michael Rützler; Kirsten Nørgaard; John D Nieland; Tae-Hwan Kwon; Søren Nielsen
Journal:  Int J Mol Sci       Date:  2016-12-07       Impact factor: 5.923

Review 7.  Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.

Authors:  Muhammad Shahnawaz Soyfoo; Clara Chivasso; Jason Perret; Christine Delporte
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

8.  Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.

Authors:  Lidia Stork; David Ellenberger; Klemens Ruprecht; Markus Reindl; Tim Beißbarth; Tim Friede; Tania Kümpfel; Lisa A Gerdes; Mareike Gloth; Thomas Liman; Friedemann Paul; Wolfgang Brück; Imke Metz
Journal:  Acta Neuropathol       Date:  2020-01-16       Impact factor: 17.088

9.  Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders.

Authors:  Pablo García-Miranda; Francisco J Morón-Civanto; Maria Del Mar Martínez-Olivo; Nela Suárez-Luna; Reposo Ramírez-Lorca; Lucía Lebrato-Hernández; Raquel Lamas-Pérez; Guillermo Navarro; Javier Abril-Jaramillo; Maria Isabel García-Sánchez; José Luis Casado-Chocán; Antonio José Uclés-Sánchez; Mercedes Romera; Miriam Echevarría; María Díaz-Sánchez
Journal:  Int J Mol Sci       Date:  2019-11-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.